Clinical Study

S1802- Phase III Randomized Trial Of Standard Systemic Therapy (Sst) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery Or Radiation) Of The Primary Tumor In Metastatic Prostate Cancer

Posted Date: Oct 1, 2019

  • Investigator: John Morris
  • Specialties: Cancer, Oncology, Prostate Cancer
  • Type of Study: Drug

The goal of this study is to compare overall survival in metastatic prostate cancer patients who are randomized to standard systemic therapy (SST) plus definitive treatment of the primary tumor versus standard systemic therapy alone

Criteria:

To Be Eligible: Must Be Diagnosed With Prostate Cancer, >18 Years Of Age, No Other Prior Malignancy

Keywords:

Prostate Cancer, Oncology, Metastatic

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.